Litigation Details for Gilead Sciences v. Sigmapharm Labs (Fed. Cir. 2014)
✉ Email this page to a colleague
Gilead Sciences v. Sigmapharm Labs (Fed. Cir. 2014)
| Docket | ⤷ Try a Trial | Date Filed | 2014-05-05 |
| Court | Court of Appeals for the Federal Circuit | Date Terminated | |
| Cause | Assigned To | ||
| Jury Demand | Referred To | ||
| Patents | 10,066,017; 6,451,340 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Gilead Sciences v. Sigmapharm Labs
The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .
Biologic Drugs cited in Gilead Sciences v. Sigmapharm Labs
The biologic drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for Gilead Sciences v. Sigmapharm Labs (Fed. Cir. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2014-07-10 | 25 | EXAMPLE45 1=10). 66.17 (C-4'. d. J=1S9), 43.12 (C-1'). lR (KBr…the FDA that the ’340 patent and U.S. Patent No. 5,663,159 (“the ’159 patent”), listed in the U.S.…States patents assigned or licensed to Gilead, namely U.S. Patent No. 5,663,159 (“the ’159 patent”) and… infringement of the ’159 patent and the ’340 patent (collectively “Patents-In-Suit”), as well as …The ’159 Patent With respect to the ’159 patent, Sigmapharm contends that the patent was invalid | External link to document | |
| 2014-08-21 | 31 | position with respect to U.S. Patent No. 6,451,340 (the “’340 Patent”) was anything other than a …infringe the ’159 Patent or the ’340 Patent, and alleging that the ’159 Patent was invalid. On …infringing claims of U.S. Patent Nos. 6,848,072 (the ’072 patent), 7,028,244 (the ’244 patent), …listed United States patents assigned or licensed to Gilead, namely ’159 Patent claims AD and expires…of certain asserted claims of the ’159 Patent (i.e., the patent covering, inter alia, the compound | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
